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ABSTRACT 
Activation of Akt signaling pathway has been documented in various human malignancies, 
including breast carcinoma. The objective of this study is to determine the incidence of Akt 
phosphorylation in breast tumours and its relationship with expression of ER-α, ER-β, HER2, 
Ki-67 and phosphorylated Bcl-2 associated death domain (p-BAD). Immunohistochemical 
staining was performed to detect these molecules on 43 paraffin-embedded breast tumour 
tissues with commercially available antibodies. Eighteen (41.9%), 3 (7.0%), 23 (53.5%), 35 
(81.4%), 21 (48.8%), 29 (67.4%), and 34 (81.0%) of breast tumours were positive for nuclear 
ER-α, nuclear ER-β, membranous HER2, cytonuclear p-Akt (Thr308), p-Akt (Ser473), p-
BAD and Ki-67, respectively. ER-α expression was inversely correlated with HER2 and Ki-
67 (P=0.041 and P=0.040, respectively). The p-Akt (Ser473) was correlated with increased 
level of p-BAD (Ser136) (P=0.012). No relationship of Akt phosphorylation with HER2, ER-
α or ER-β was found. The p-Akt (Ser473) immunoreactivity was significantly higher in stage 
IV than in stage I or II (P=0.036 or P=0.009). The higher Ki-67 and lower ER-α expression 
showed an association with patient age of <50 years (P=0.004) and with positive nodal 
status(P=0.033), respectively. Our data suggest that the Aktphosphorylation and inactivation 
of its downstream target, BAD may play a role in survival of breast cancer cell. This study 
does not support the simple model of linear HER2/ PI3K/Akt pathway in breast cancer. 
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